Discontinued — last reported Q3 '25
Over 2 years (FY 2021 to FY 2025), Impairment Charges shows an upward trend with a 39.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase signals poor past investment decisions or deteriorating market conditions, which is generally viewed negatively by investors.
These are non-cash charges recognized when the carrying value of an asset exceeds its fair market value. Such charges in...
Common in large, diversified firms that frequently acquire or divest business units.
impairment_charges| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $78.00M | $0.00 | $1.24B | $395.00M | $74.00M | $0.00 | $152.00M | $128.00M | $0.00 | $593.00M | $1.31B | $0.00 | $2.57B | $0.00 | $0.00 | $13.00M |
| QoQ Change | — | -100.0% | — | -68.1% | -81.3% | -100.0% | — | -15.8% | -100.0% | — | +120.9% | -100.0% | — | -100.0% | — | — |
| YoY Change | — | — | — | +406.4% | — | -100.0% | +105.4% | — | — | +290.1% | — | -100.0% | — | -100.0% | -100.0% | — |
| Segment | Q2 '22 | Q3 '22 | Q3 '23 | Q3 '24 |
|---|---|---|---|---|
| North America | $395.00M | $50.00M | $139.00M | $560.00M |
| International Developed Markets | — | $17.00M | $13.00M | $33.00M |
| Total | $395.00M | $74.00M | $152.00M | $593.00M |
International Developed Markets, North America were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.